Filing Details
- Accession Number:
- 0001408408-17-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-21 17:37:31
- Reporting Period:
- 2017-07-19
- Filing Date:
- 2017-07-21
- Accepted Time:
- 2017-07-21 17:37:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1130166 | Cyclacel Pharmaceuticals Inc. | CYCC | Pharmaceutical Preparations (2834) | 911766850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1331271 | Bryan Kenneth Dart | P. O. Box 31300 Grand Cayman E9 KY1-1206 | No | No | Yes | No | |
1408408 | Ltd Capital Eastern | 10 Market Street, #773 Camana Bay Grand Cayman E9 KY1-9006 | No | No | Yes | No | |
1488856 | Ltd. Services Portfolio | 10 Market Street, # 773 Camana Bay Grand Cayman E9 KY1-9006 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-07-19 | 850,000 | $2.00 | 2,167,261 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2017-07-19 | 1 | $0.00 | 850,000 | $2.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1 | No | 4 | P | Direct |
Footnotes
- On July 19, 2017 Eastern Capital Limited acquired 850,000 Class A Units. Each Class A Unit consists of one share of the Issuer's common stock and a warrant to purchase one share of the Issuer's common stock which is exercisable as of July 21, 2017 with an exercise price of $2.00 per share and which expires on July 22, 2024.